The latest member of the CHN ecosystem is Medixine from Espoo. The company offers a comprehensive remote care platform for remote monitoring and patient communication. We spoke with Medixine’s Chairman of the Board, Dr. Tapio Jokinen, about the company’s core areas of expertise and expectations related to future collaboration.
Tapio Jokinen, who trained as a medical doctor, has been involved in various companies developing medical technologies and currently serves as Chairman of the Board at Medixine. Jokinen says that Medixine employs around 15 people, with employees also based in the USA and the UK. Founded in 1995, Medixine initially developed project-based healthcare solutions, but now focuses on remote patient monitoring products. The company’s use-case-independent solution integrates all the monitoring devices needed for remote care onto a single platform, from which healthcare professionals can monitor various illnesses or health conditions and receive real-time information about patients requiring urgent care.
Medixine’s systems are in production use in the USA as well as in Spain and Portugal in dozens of hospitals and in pilots in Finland and Denmark. Medixine’s customers include Linde Healthcare, Tunstall, Nonin and Roche Diagnostics.
Jokinen explains that Medixine has been looking for a clinical partner to identify suitable use cases for Medixine’s horizontal approach. Joining the CHN ecosystem, led by HUS Helsinki University Hospital, was of particular interest to Medixine to be able to co-develop new remote monitoring solutions based on real need and contents defined by a significant clinical operator such as HUS. Medixine has also recently completed a research project, supported by Business Finland, exploring the application of AI in remote patient monitoring. HUS’s data lake could provide patient-record data for prototyping the developed system, enabling better data monitoring models. Discussions with HUS about these forms of collaboration have already begun.
Jokinen hopes that cooperation with other CHN member companies will result in feasible, jointly developed solutions that can be commercialised internationally. CHN seeks complementary expertise and joint projects, on which Jokinen comments as follows: “When a group of partners gets to know each other well, it’s important to identify each party’s areas of expertise and to combine efforts to achieve the best possible outcome.”
Jokinen states: “Medixine brings to the CHN ecosystem a robust and scalable system for remote measurements and collecting patient data in a secure environment. We have strong expertise in remote patient monitoring in a variety of use cases, and we hope clinicians will provide their insights into actual clinical needs.” He envisions Medixine’s expectations of the cooperation as follows: “It would be fantastic if, thanks to our collaboration, we could establish a good cooperation model for utilising HUS’s data and clinical expertise to co-develop and productise new solutions for important use cases for the global market.”
